Co-Diagnostics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for CODX, updated each market day.
CODX AI Sentiment
AI predicts Co-Diagnostics, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Co-Diagnostics, Inc. Common Stock
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Sector
Exchange
Market Cap
$5,187,549
Cap Tier
Employees
115
Headquarters
SALT LAKE CITY, UT
Listed Since
July 12, 2017
Website
CODX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CODX Volatility
Co-Diagnostics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
